skip to the content

 

Rheumatoid Arthritis

MabThera (rituximab)

MabThera (rituximab)

Indicated for the treatment of certain types of non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, severe active rheumatoid arthritis and induction of remission in adult patients with severe, active Granulomatosis with polyangiitis (Wegener's) (GPA) and Microscopic polyangiitis (MPA).

(This is a brief indication for use; for details see SPC) 

SPC - Mabthera 100mg and 500mg Concentrate for Solution for Infusion
PIL - Mabthera 100mg and 500mg Concentrate for Solution for Infusion

Mabthera information at Medicine Guides

Naprosyn (naproxen)

Naprosyn (naproxen)

Indicated in the treatment of rheumatoid arthritis and other musculoskeletal disorders.

(This is a brief indication for use; for details see SPC) 

SPC - Naprosyn 250mg and 500mg Tablets
PIL - Naprosyn 250mg and 500mg Tablets
SPC - Naprosyn EC 250mg, 375mg and 500mg Tablets
PIL - Naprosyn EC 250mg, 375mg and 500mg Tablets

Naprosyn information at Medicine Guides

RoActemra (tocilizumab)

RoActemra (tocilizumab)

Treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients, treatment of active systemic juvenile idiopathic arthritis (sJIA) and juvenile idiopathic polyarthritis (rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older.

(This is a brief indication for use; for details see SPC) 

SPC - RoActemra 20mg/ml Concentrate for Solution for Infusion
PIL – RoActemra 20mg/ml Concentrate for Solution for Infusion

SPC - RoActemra 162mg/ml for Solution for Injection in pre-filled syringe
PIL – RoActemra 162mg/ml for Solution for Injection in pre-filled syringe

RoActemra information at Medicine Guides